HVC
ANAC

Healthcare Value Capital’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Healthcare Value Capital’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-37,730
Closed -$401K – 58
2013
Q3 		$401K Hold
37,730
– – 0.35% 44
2013
Q2 		$211K Buy
+37,730
New +$228K 0.15% 56

Other funds holding ANAC

RCP
Rho Capital Partners New York $20.4M AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Healthcare Value Capital's ANAC Position: Q4 2013 in Review

Healthcare Value Capital sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q4 2013, closing a stake of 37,730 shares — an estimated $401K sold.

Healthcare Value Capital first reported a position in ANAC in Q2 2013 and held it in 2 quarters. The position peaked at $401K in Q3 2013. 87 funds tracked by Wall St. Rank hold ANAC as of Q4 2013.

  • Healthcare Value Capital reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q4 2013 after selling out during the quarter.
  • Healthcare Value Capital sold 37,730 ANACOR PHARMACEUTICALS INC COM shares in Q4 2013, an estimated $401K.
  • Healthcare Value Capital first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2013 and held it in 2 quarters.
  • Healthcare Value Capital's ANACOR PHARMACEUTICALS INC COM position peaked at $401K in Q3 2013.
  • 87 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q4 2013.

Based on Healthcare Value Capital's 13F filing for Q4 2013, filed 13 Feb 2014.